Neuroscience has entered a new era. Now it’s time for a ‘moonshot’ approach.
We know less about the brain than the bottom of the ocean or the dark side of the moon, the old adages have long claimed. But in the context of drug development, times have changed. Pharma companies have renewed their interest in long-neglected areas of …